Regeneron Pharmaceuticals, Inc.
2020 Q2 - 2025 Q4 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/5/2026 | 31,932 | 0.1% | 41,362 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 778 | 0.0% | 1,385 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 681 | 0.0% | 1,300 | 6/30/2025 |
| 2025 Q1 | 9/17/2025 | 2,083 | 0.0% | 3,283 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 90,452 | 0.3% | 118,280 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 129,093 | 0.4% | 107,989 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 128,483 | 0.5% | 112,948 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 113,319 | 0.4% | 117,881 | 3/31/2024 |
| 2023 Q4 | 5/16/2024 | 78,216 | 0.4% | 89,055 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 69,212 | 0.4% | 84,101 | 9/30/2023 |
| 2023 Q2 | 7/24/2023 | 54,001 | 0.3% | 75,154 | 6/30/2023 |
| 2023 Q1 | 5/11/2023 | 66,912 | 0.4% | 81,434 | 3/31/2023 |
| 2022 Q4 | 1/24/2023 | 53,526 | 0.4% | 74,188 | 12/31/2022 |
| 2022 Q3 | 11/4/2022 | 70,029 | 0.5% | 101,658 | 9/30/2022 |
| 2022 Q2 | 7/22/2022 | 59,849 | 0.4% | 101,245 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 1,194 | 0.0% | 1,710 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 333 | 0.0% | 527 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 324 | 0.0% | 535 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 462 | 0.0% | 827 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 355 | 0.0% | 750 | 3/31/2021 |
| 2020 Q4 | 2/24/2021 | 416 | 0.0% | 861 | 12/31/2020 |
| 2020 Q3 | 11/10/2020 | 399 | 0.0% | 713 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 1,046 | 0.0% | 1,678 | 6/30/2020 |